neutrophil
patrol
blood
continu
search
prey
present
primarili
form
bacteria
dead
die
host
cell
trillion
bacteria
colon
human
particularli
mucos
skin
surfac
task
prevent
pathogen
invas
trivial
half
million
peopl
north
america
year
system
fail
sever
sepsi
ensu
kill
approxim
onethird
peopl
therefor
understand
behavior
immun
system
respons
pathogen
particularli
role
neutrophil
essenti
much
urgenc
regard
antibioticresist
bacteria
staphylococcu
aureu
multidrugresist
gramneg
bacilli
rise
virus
sar
corona
viru
influenza
virus
make
host
suscept
secondari
infect
also
becom
promin
tweak
host
immun
may
way
fight
emerg
pathogen
addit
inflamm
occur
blood
vessel
result
infect
inflamm
also
occur
intravascularli
consequ
cell
death
steril
injuri
whether
neutrophil
discrimin
steril
injuri
infect
clear
molecular
mechan
mediat
neutrophil
recruit
quit
variabl
ultim
perform
function
neutrophil
need
know
go
therefor
effici
neutrophil
guidanc
vasculatur
affect
tissu
site
crucial
normal
govern
chemotact
gradient
system
infect
system
alter
highest
concentr
chemokin
chemotact
agent
found
plasma
revers
chemotact
gradient
result
activ
neutrophil
within
vasculatur
mani
year
prevail
view
neutrophil
get
stuck
capillari
bed
lung
liver
releas
cytotox
content
induc
inappropri
tissu
injuri
lead
multiorgan
failur
howev
recent
explan
put
forth
suggest
sequestr
neutrophil
lung
liver
benefici
host
surviv
new
somewhat
unorthodox
way
neutrophil
may
fight
bacteri
infect
blood
describ
one
exampl
neutrophil
shown
expel
dna
form
neutrophil
extracellular
trap
net
ensnar
bacteria
die
interact
platelet
neutrophil
essenti
process
occur
vasculatur
review
discuss
recent
work
pertain
neutrophil
recruit
function
steril
injuri
infecti
stimuli
use
sepsi
exampl
war
neutrophil
bacteria
intrigu
approach
implement
host
pathogen
attempt
get
upper
hand
also
discuss
emerg
role
neutrophil
tissu
repair
angiogenesi
mani
discoveri
reli
experiment
mous
model
inflamm
newli
evolv
imag
technolog
pay
particular
attent
studi
howev
noteworthi
relev
mani
observ
mice
remain
confirm
human
last
year
multistep
process
neutrophil
recruit
blood
tissu
extens
studi
use
variou
vivo
microscopi
approach
summar
fig
vivo
spinningdisk
confoc
laserscan
confoc
twophoton
microscopi
enabl
refin
highresolut
examin
neutrophil
behavior
context
cell
allow
research
follow
interact
neutrophil
surround
endothelium
interendotheli
junction
well
behavior
emigr
vasculatur
focu
neutrophil
key
regulatori
role
vascular
inflamm
recent
studi
use
advanc
imag
techniqu
yield
new
insight
mechan
neutrophil
contribut
defens
bacteri
infect
also
steril
injuri
set
neutrophil
recruit
variou
mechan
depend
situat
also
describ
process
may
disrupt
system
infect
particular
emphasi
mous
model
sepsi
neutrophil
often
immobil
lung
liver
system
infect
immobil
may
mechan
bacteria
evad
innat
immun
respons
allow
neutrophil
form
neutrophil
extracellular
trap
trap
kill
bacteria
blood
platelet
also
import
player
sepsi
describ
collabor
neutrophil
format
neutrophil
extracellular
trap
local
tissu
infect
thought
activ
sentinel
cell
includ
dendrit
cell
macrophag
mast
cell
endotheli
cell
perhap
parenchym
cell
induc
recruit
circul
neutrophil
infect
tissu
addit
monocyt
crawl
along
lumen
blood
vessel
may
infiltr
tissu
earli
infect
recruit
neutrophil
upregul
adhes
molecul
selectin
endothelium
essenti
initi
neutrophil
recruit
pselectin
store
weibelpalad
bodi
within
rest
endotheli
cell
eselectin
synthes
de
novo
transloc
apic
cell
membran
transient
bind
ligand
neutrophil
includ
pselectin
glycoprotein
eselectin
glycosyl
ligand
fig
transient
interact
selectin
ligand
neutrophil
result
neutrophil
tether
roll
first
step
leukocyt
recruit
cascad
molecular
guidanc
signal
chemoattract
chemokin
origin
infect
releas
tissu
leukocyt
form
gradient
guid
leukocyt
site
infect
g
proteincoupl
receptor
roll
neutrophil
bind
chemokin
sequest
apic
endothelium
lead
insideout
signal
induc
conform
chang
integrin
express
neutrophil
increas
avid
affin
thu
result
neutrophil
arrest
subsequ
intravascular
crawl
transmigr
site
neutrophil
express
high
level
integrin
itgal
also
known
l
itgam
also
known
distinct
role
molecul
recent
describ
involv
firm
adhes
crucial
intravascular
crawl
neutrophil
crawl
mononuclear
cell
shear
contribut
direct
crawl
neutrophil
adher
neutrophil
venul
immedi
start
crawl
perpendicular
blood
flow
behavior
confirm
vitro
shear
appli
adher
neutrophil
teleolog
endotheli
cell
elong
direct
flow
perpendicular
crawl
allow
neutrophil
find
endotheli
junction
shortest
period
time
inher
respons
shear
might
import
rapid
transmigr
neutrophil
shown
preferenti
transmigr
junction
unless
crawl
specif
inhibit
mice
neutrophil
crawl
within
vasculatur
consequ
transcellular
transmigr
endotheli
cell
predomin
endotheli
cell
activ
respons
transmigr
form
dock
structur
endotheli
project
vivo
result
dome
surround
entir
neutrophil
endotheli
membran
protein
includ
aid
neutrophil
emigr
addit
adhes
molecul
help
neutrophil
move
across
basement
membran
area
low
express
laminin
collagen
ref
revers
migrat
back
vessel
prevent
endotheli
jamc
tissu
infect
numer
neutrophil
recruit
local
blood
also
mobil
bone
marrow
result
blood
neutrophilia
ensur
adequ
neutrophil
suppli
key
molecul
neutrophil
mobil
bone
marrow
includ
leukotrien
cxc
chemokin
rodent
key
molecul
also
known
kc
also
known
wherea
stromal
cellderiv
receptor
involv
neutrophil
retent
bone
marrow
howev
also
crucial
neutrophil
mobil
infect
sepsi
product
bone
marrow
reduc
system
product
increas
result
invert
gradient
direct
neutrophil
bone
marrow
circul
chemokin
signal
get
establish
flow
blood
earli
work
propos
proinflammatori
molecul
plateletactiv
factor
embed
membran
activ
endothelium
function
juxtacrin
manner
activ
polar
neutrophil
evid
emerg
chemokin
also
form
gradient
within
vascular
compart
experi
chemokin
sourc
place
one
side
blood
vessel
show
crawl
neutrophil
direct
emigr
side
vessel
heparan
sulfat
necessari
process
heparan
sulfat
residu
surfac
endothelium
prevent
dissolut
chemokin
gradient
blood
provid
local
direct
cue
crawl
neutrophil
observ
made
use
chemokin
notabl
differ
chemokin
bind
differ
affin
heparan
sulfat
whether
chemokin
establish
heptotact
gradient
remain
unclear
r
e
v
e
w
numer
chemoattract
releas
form
gradient
bacteri
infect
partli
bacteria
complement
fragment
eman
bacteria
also
nearbi
activ
macrophag
endotheli
cell
neutrophil
shown
respond
guidanc
signal
hierarch
manner
prefer
endtarget
chemoattract
factor
bacteri
product
exampl
nformylmethionineleucinephenylalanin
fmlp
intermedi
chemokin
prefer
rais
possibl
separ
signal
pathway
activ
neutrophil
respons
fmlp
notabl
fmlp
activ
pathway
activ
class
isoform
phosphatidylinositol
phosphoryl
membran
lipid
lead
edg
neutrophil
fig
time
phosphatas
tensin
homolog
pten
local
side
back
crawl
cell
therebi
convert
back
area
cell
away
lead
edg
worth
mention
bodi
work
suggest
ship
rather
pten
import
phosphatas
process
mechan
thought
allow
neutrophil
recogn
amplifi
shallow
gradient
molecul
along
length
know
must
move
direct
oppos
gradient
pten
surround
entir
cell
circumfer
fig
gradient
recogn
howev
pathway
activ
chemoattract
surround
entir
cell
neutrophil
ever
detect
gradient
number
group
shown
fmlp
also
activ
mitogenactiv
protein
kinas
mapk
fig
fmlpinduc
mapk
allow
neutrophil
respond
bacteri
product
fig
addit
molecul
contribut
chemoattract
signal
migrat
cell
rang
dictyostelium
neutrophil
describ
recent
exampl
ref
cgmp
phosphatid
acid
whether
redund
distinct
function
fit
hierarch
natur
neutrophil
chemotaxi
remain
unclear
although
formal
evid
multipl
vivo
gradient
chemoattract
exist
hard
imagin
neutrophil
could
move
numer
compart
substanti
distanc
use
singl
gradient
one
consid
neutrophil
adher
endothelium
activ
endotheli
produc
apic
sequest
unless
second
chemoattract
releas
affect
tissu
difficult
understand
neutrophil
would
move
vasculatur
away
vessel
emigr
neutrophil
need
migrat
toward
bacteri
focu
die
cell
without
distract
would
oppos
gradient
come
vasculatur
receptor
intern
allow
second
chemoattract
domin
sequenti
manner
could
occur
altern
hierarch
respons
may
take
place
fmlp
endtarget
chemoattract
inhibit
signal
recent
vivo
experi
show
neutrophil
sinusoid
vessel
initi
crawl
along
gradient
ignor
signal
follow
new
gradient
fmlp
receptor
ligand
laid
gradient
thu
gain
access
precis
tissu
site
fig
therefor
grow
evid
indic
neutrophil
recruit
vivo
result
releas
multipl
chemoattract
synergist
oppos
effect
involv
signal
molecul
like
govern
neutrophil
recruit
afflict
tissu
highli
regul
mechan
control
neutrophil
chemotaxi
alter
system
infect
perhap
disrupt
mous
model
endotoxemia
sepsi
system
infect
presum
occur
corollari
neutrophil
migrat
defect
consist
report
septic
individu
sepsi
clinic
defin
presenc
infect
plu
follow
fever
tachypnea
edema
increas
decreas
white
blood
cell
count
high
serum
concentr
chemokin
creactiv
protein
hemodynam
alter
multipl
organ
begin
fail
lead
sever
sepsi
sever
sepsi
one
highest
mortal
rate
diseas
state
importantli
anyon
age
suscept
sepsi
although
young
old
r
e
v
e
w
highest
risk
delay
immun
respons
like
increas
mortal
make
rapid
neutrophil
recruit
key
endogen
host
defens
mechan
inde
neutropen
individu
highli
suscept
sepsi
despit
clear
need
effect
neutrophil
function
overexuber
neutrophil
potenti
injur
bystand
tissu
part
infect
site
fact
mani
year
neutrophil
therapeut
target
sepsi
total
elimin
neutrophil
would
lead
death
alter
modifi
action
may
potenti
clinic
benefit
endotoxemia
sepsi
human
experiment
model
whole
chemotact
process
may
disrupt
highest
concentr
chemokin
chemotact
agent
found
circul
plasma
activ
endothelium
well
neutrophil
within
blood
vessel
addit
uncontrol
exposur
neutrophil
plasma
chemokin
result
downregul
chemokin
receptor
individu
sever
sepsi
well
downregul
lipopolysaccharid
lp
treat
mice
impair
chemotaxi
result
insuffici
leukocyt
recruit
sourc
infect
furthermor
molecul
lp
activ
mapk
key
signal
pathway
fmlpinduc
chemotaxi
tolllik
receptor
thu
disrupt
chemotact
process
although
lp
sometim
mistaken
chemotact
molecul
induc
chemotaxi
instead
function
stop
signal
overrid
chemoattract
fig
function
also
observ
tumor
necrosi
fact
lp
downregul
human
mous
neutrophil
therebi
inhibit
chemotaxi
toward
human
toward
kc
mice
downregul
prevent
inhibit
receptor
intern
lipoteicho
acid
compon
gramneg
cell
wall
ligand
shown
caus
downregul
would
reduc
neutrophil
chemotaxi
clear
bacteri
product
activ
tlr
may
disrupt
neutrophil
chemotaxi
data
consist
improv
bacteri
local
clearanc
observ
mice
express
tlr
endothelium
neutrophil
immun
cell
wildtyp
mice
tlr
macrophag
immun
cell
system
releas
mani
chemokin
cytokin
may
distract
neutrophil
prevent
locat
bacteria
addit
circul
activ
neutrophil
becom
rigid
trap
within
small
capillari
lung
liver
sinusoid
therebi
prevent
find
bacteria
compart
like
peritoneum
bacteria
may
eman
final
certain
bacteri
proteas
shown
cleav
inactiv
cxc
chemokin
therebi
imped
chemotaxi
neutrophil
sourc
infect
decreas
bacteri
clearanc
increas
system
dissemin
mechan
underli
disrupt
neutrophil
chemotaxi
system
infect
summar
elsewher
includ
activ
lowaffin
fmlp
receptor
inactiv
highaffin
fmlp
receptor
respons
chemotaxi
nitric
oxid
known
antiadhes
properti
mediat
downregul
endotheli
adhes
molecul
induct
vast
amount
induc
synthas
could
also
reduc
neutrophil
chemotaxi
moreov
therapeut
administ
inhal
given
septic
individu
pulmonari
hypertens
could
dislodg
neutrophil
lung
might
benefici
could
also
inhibit
chemotaxi
necessari
site
mani
unansw
question
role
sepsi
gener
inhibit
may
actual
harm
septic
individu
although
specif
inhibit
induc
synthas
could
perhap
benefit
final
peroxisom
proliferatoractiv
seem
endogen
inhibitor
chemotaxi
molecul
activ
sepsi
could
also
contribut
neutrophil
impair
addit
disrupt
chemokin
signal
observ
sepsi
neutrophil
adhes
molecul
may
also
alter
neutrophil
recruit
liver
lung
seem
use
selectinand
integrinindepend
adhes
mechan
respons
bacteremia
system
lp
administr
lung
adhes
mechan
remain
unknown
investig
suggest
physic
trap
rather
adhes
molecul
may
domin
although
physic
trap
neutrophil
sequestr
liver
also
propos
recent
shown
account
adhes
liver
endotoxemia
bacteri
sepsi
model
seem
unclear
human
evolv
mechan
counter
pathogendisrupt
pathway
howev
possibl
chang
neutrophil
may
actual
attempt
help
host
rather
simpli
dysregul
would
crawl
emigr
neutrophil
help
erad
pathogen
blood
perhap
neutrophil
sequestr
lung
liver
import
surviv
benefit
discuss
later
review
r
e
v
e
w
although
mous
model
use
observ
sepsisrel
phenomena
human
data
often
less
clear
notabl
differ
experiment
clinic
sepsi
term
concentr
bacteria
bacteri
compon
circul
diseas
progress
rodent
highli
resist
infect
compar
human
lp
dose
use
induc
sepsi
mice
typic
mg
per
kg
bodi
weight
time
higher
determin
induc
sever
sepsi
human
furthermor
organ
failur
major
crucial
compon
sepsi
syndrom
human
readili
studi
mice
receiv
high
dose
lp
bacteria
die
develop
secondari
complic
therefor
result
model
cecal
ligat
punctur
mice
although
variabl
may
better
reflect
human
condit
even
though
elev
level
chemokin
cytokin
mani
proinflammatori
molecul
well
sever
chemotact
defect
report
individu
sever
sepsi
import
mani
mechan
discuss
remain
confirm
human
anoth
form
vascular
inflamm
steril
inflamm
moreov
paradox
steril
injuri
contribut
major
way
infect
sepsi
asid
potenti
kill
host
hyperreact
immun
mani
bacteria
virus
caus
cell
death
cell
lysi
lead
releas
multipl
molecul
associ
steril
injuri
moreov
hypotens
develop
traumat
septic
shock
tissu
ischemia
caus
hypoperfus
progress
ischemia
follow
reperfus
aggress
volum
resuscit
rapid
blood
transfus
procedur
use
treat
hypotens
reperfus
injuri
form
steril
injuri
studi
year
role
neutrophil
oxid
proteas
clearli
establish
deplet
neutrophil
blockad
neutrophil
respons
effect
reduc
patholog
ischemia
reperfus
also
trauma
druginduc
hepatotox
mode
steril
injuri
injuri
caus
cell
lysi
vivo
releas
mani
proinflammatori
damageassoci
molecular
pattern
molecul
damp
also
call
alarmin
danger
signal
host
compon
releas
gener
tissu
injuri
inher
proinflammatori
activ
therebi
alert
innat
immun
system
number
comprehens
review
cover
ident
function
individu
danger
signal
recent
publish
damp
may
proteolyt
oxid
modifi
extracellular
molecul
exampl
digest
hyaluronan
precipit
uric
acid
crystal
intracellular
substanc
activ
secret
respons
cell
stress
exampl
high
mobil
group
protein
passiv
releas
cell
membran
integr
compromis
exampl
atp
damp
pathogenassoci
molecular
pattern
function
similarli
stimul
pattern
recognit
receptor
tlr
nodlik
receptor
nlr
nlr
compris
famili
protein
mostli
cytoplasm
recogn
hostderiv
dangerassoci
molecul
activ
lead
assembl
complex
high
molecular
mass
call
inflammasom
induc
gener
activ
product
matur
discoveri
nodlik
receptor
famili
pyrin
domaincontain
inflammasom
activ
hostderiv
particul
matter
uric
acid
crystal
atp
led
implic
number
inflammatori
diseas
nonpatternrecognit
receptor
includ
receptor
advanc
glycat
end
product
rage
also
contribut
onset
inflamm
sever
model
steril
injuri
despit
much
damp
divers
organ
andor
insult
specif
mani
pathway
converg
act
central
orchestr
inflamm
cell
recruit
nuclear
signal
pathway
lead
format
chemoattract
gradient
although
mani
damp
may
indirectli
recruit
neutrophil
none
function
true
chemoattract
neutrophil
recruit
recent
two
independ
studi
report
mitochondrialderiv
formylpeptid
ligand
function
chemotact
damp
figur
supplementari
video
show
follow
thermal
injuri
mani
neutrophil
enter
injuri
site
within
hour
although
injuri
steril
inhibit
fmlp
receptor
fig
normal
associ
respons
bacteri
product
effici
way
inhibit
neutrophil
hauser
colleagu
show
neutrophil
crawl
toward
injur
mitochondria
movement
could
also
abrog
fmlp
receptor
inhibitor
observ
may
explain
fact
mitochondria
origin
ancient
bacteria
becom
endosymbiont
insid
cell
multicellular
organ
formyl
peptid
synthes
mitochondri
genom
suggest
neutrophil
respond
mitochondria
similar
way
bacteria
unclear
whether
neutrophil
distinguish
dead
cell
bacteria
whether
dead
cell
unleash
neutrophilkil
mechan
bacteria
whether
respons
ultim
benefici
host
clear
overlap
infect
steril
injuri
condit
like
sepsi
mitochondri
injuri
often
observ
sepsi
inhibit
mitochondri
injuri
reduc
patholog
model
sepsi
although
result
initi
seem
counterintuit
inhibit
formyl
peptid
receptor
may
therefor
potenti
therapeut
rout
profound
bacteri
infect
multipl
signal
releas
dead
cell
indic
complex
respons
simpl
steril
injuri
superimpos
multitud
infecti
stimuli
top
injuri
make
thing
far
complex
experi
attempt
address
issu
filter
contain
fmlp
place
liver
surfac
neutrophil
crawl
use
liver
sinusoid
toward
site
presenc
lp
neutrophil
adher
liver
sinusoid
use
rather
integrin
crawl
toward
fmlp
chang
neutrophil
chemotaxi
adhes
caus
lpsmediat
downregul
neutrophil
interleukin
relat
mechan
remov
restor
abil
neutrophil
crawl
toward
fmlp
even
presenc
lp
thu
crucial
mechan
greatli
elev
sepsi
deem
respons
delay
immunosuppress
phase
follow
initi
potent
inflammatori
phase
condit
box
mous
model
sepsi
induc
escherichia
coli
express
lp
fmlp
neutrophil
recruit
liver
depend
independ
neutrophil
crawl
observ
liver
show
lp
overrod
fmlp
signal
key
question
whether
recruit
adhes
neutrophil
liver
mechan
allow
bacteria
evad
host
immun
respons
rather
benefici
respons
host
benefit
might
netmedi
trap
bacteria
process
discuss
neutrophil
essenti
restitut
import
compon
inflamm
resolut
phase
studi
focus
neutrophil
recruit
stage
r
e
v
e
w
turn
molecul
resolvin
take
center
stage
howev
neutrophil
may
also
contribut
tissu
restitut
angiogenesi
neutrophil
produc
store
proangiogen
molecul
vascular
endotheli
growth
factor
vegfa
matrix
within
granul
vegf
key
player
blood
vessel
format
direct
chemotact
effect
endotheli
cell
proangiogen
function
attribut
abil
releas
vegf
growth
factor
bound
extracellular
matrix
digest
extracellular
matrix
pave
way
new
vessel
neutrophil
cell
bodi
releas
free
endogen
inhibitor
timp
therefor
capabl
deliv
highli
activ
angiogen
site
proangiogen
capac
neutrophil
shown
corneal
injuri
model
number
infiltr
neutrophil
posit
correl
angiogenesi
vegf
level
neutrophil
deplet
markedli
impair
releas
vegf
tissu
heal
model
furthermor
anoth
studi
show
isol
pancreat
islet
transplant
muscl
revascular
neutropen
mice
wherea
intraislet
vasculatur
restor
transplant
wildtyp
mice
show
recruit
neutrophil
import
initi
angiogenesi
outsid
focu
review
worth
mention
grow
evid
neutrophil
may
also
contribut
cancer
effect
angiogenesi
final
import
point
neutrophil
purport
recruit
monocyt
may
help
remov
dead
die
neutrophil
might
also
assist
angiogenesi
restitut
discuss
previous
neutrophil
key
role
fight
bacteri
infect
static
vitro
condit
neutrophil
effect
chase
phagocytos
bacteria
vivo
flow
condit
blood
expect
highli
ineffici
process
howev
neutrophil
seem
adapt
addit
mechan
fight
bacteria
neutrophil
shown
releas
dna
netlik
fashion
presenc
variou
bacteria
creat
trap
call
net
net
cover
proteas
includ
elastas
antimicrobi
molecul
histon
toxic
molecul
may
contribut
host
cell
injuri
howev
similar
vivo
observ
net
yet
publish
perhap
difficulti
imag
event
blood
net
format
shown
start
product
oxid
neutrophil
follow
degrad
nuclear
envelop
dna
releas
cell
culmin
neutrophil
lysi
h
activ
phorbol
bacteria
separ
studi
eosinophil
neutrophil
found
catapult
dna
cell
extracellular
space
dna
sourc
nonnuclear
instead
dna
origin
mitochondria
howev
group
report
role
mitochondri
dna
document
presenc
histon
net
suggest
nuclear
sourc
dna
addit
direct
antimicrobi
effect
also
evid
histon
may
regulatori
role
net
format
process
net
format
start
histon
hypercitrullin
decondens
associ
nuclear
chromatin
net
format
induc
lp
fmlp
shigella
flexneri
increas
histon
citrullin
occur
peptidylarginin
deiminas
citrullin
convers
posit
charg
arginin
side
chain
polar
uncharg
citrullin
side
chain
deimin
although
five
known
peptidylarginin
deiminas
human
peptidylarginin
deiminas
express
neutrophil
classic
nuclear
local
signal
inhibit
shown
prevent
histon
citrullin
substanti
reduc
net
releas
howev
addit
benefici
role
histon
esmon
colleagu
recent
show
histon
injur
endothelium
also
found
activ
protein
c
apc
therapeut
protein
approv
treat
sepsi
disabl
histon
toxic
preserv
host
cell
interestingli
aureu
also
shown
induc
net
within
min
neutrophil
activ
oxidantindepend
mechan
howev
condit
neutrophil
continu
exclud
vital
dye
suggest
lyse
net
found
releas
independ
neutrophil
lysi
vesicular
mechan
figur
summar
process
first
show
profound
round
decondens
nucleu
follow
format
larg
bleblik
structur
inner
outer
nuclear
membran
vesicl
pinch
nuclear
membran
ultim
releas
net
process
seen
first
min
neutrophil
activ
neutrophil
lysi
observ
eventu
nuclear
membran
complet
sepsi
system
respons
character
two
phase
first
initi
hyperinflammatori
state
occur
also
refer
system
inflammatori
respons
syndrom
follow
pronounc
immunosuppress
abil
recogn
sever
sepsi
earlier
allow
clinic
intervent
consist
earli
resuscit
administr
appropri
antibiot
howev
intervent
also
result
chang
time
septic
mortal
earli
cours
ill
later
intens
care
unit
hospit
individu
state
immunosuppress
like
initi
hyperinflammatori
phase
set
immunoparalysi
phase
phase
multifacet
surpris
major
clinic
trial
focus
antiinflammatori
strategi
target
singl
inflammatori
mediat
resound
failur
exampl
block
nitric
oxid
thrombin
tpfi
mani
molecul
fail
sepsi
trial
current
aggress
fluid
replac
rapid
administr
broad
spectrum
antibiot
crucial
improv
mortal
apc
help
individu
howev
even
apc
second
trial
individu
sever
sepsi
initi
assess
effect
safeti
treatment
one
import
issu
address
trial
design
potenti
sepsi
therapi
current
subject
sepsi
group
togeth
regardless
caus
sepsi
type
infect
often
immedi
known
time
studi
enrol
recent
clinic
trial
one
examin
inhibitor
detect
primarili
gramneg
infect
would
test
inhibitor
subject
even
gramposit
infect
final
microvascular
hypercoagul
dissemin
intravascular
coagul
substanti
problem
sepsi
current
specif
therapi
apc
seem
benefici
current
intraven
heparin
test
treatment
sepsi
although
thrombocytopenia
like
poor
prognost
sign
sepsi
clinic
trial
specif
block
platelet
function
sepsi
attempt
knowledg
necessari
evalu
whether
target
cell
clinic
benefit
futur
studi
r
e
v
e
w
broke
perhap
lead
releas
net
lytic
event
later
time
point
h
activ
nonlyt
rapid
releas
dna
observ
respons
platelet
bind
neutrophil
fig
mani
bacteria
make
dnase
presum
intend
degrad
net
allow
bacteri
dissemin
inde
presenc
dnase
increas
virul
variou
bacteri
strain
may
clinic
relev
dnase
standard
treatment
individu
cystic
fibrosi
help
clear
lung
debri
net
report
lung
individu
cystic
fibrosi
whether
treatment
dnase
affect
bacteri
clearanc
suscept
infect
remain
difficult
determin
mani
medic
includ
antibiot
concomitantli
use
individu
address
mani
outstand
question
regard
benefici
detriment
aspect
net
requir
specif
net
inhibitor
current
inhibitor
also
affect
oxid
product
andor
addit
aspect
neutrophil
biolog
avail
make
difficult
elucid
precis
role
net
platelet
extens
neutrophil
grow
interest
role
platelet
inflamm
inflammatori
diseas
arthropod
hemolymph
contain
hemocyt
nucleat
circul
cell
respons
immun
well
coagul
higher
order
speci
function
diverg
special
cell
platelet
retain
essenti
immun
function
particularli
partnership
neurophil
initi
neutrophil
becom
round
uniformli
condens
chromatin
undergo
nuclear
envelop
breakdown
within
cell
small
vesicl
contain
dna
seen
cytoplasm
near
plasma
membran
dnacontain
vesicl
eventu
fuse
plasma
membran
net
releas
trap
bacteria
ii
net
also
releas
cell
lysi
typic
take
longer
vesicularmedi
mechan
nuclear
envelop
degrad
chromatin
decondens
occur
citrullin
histon
iii
net
releas
mitochondria
also
observ
one
studi
although
step
process
remain
poorli
character
figur
plateletneutrophil
interact
within
liver
vasculatur
endotoxemia
intravit
spinningdisk
confoc
visual
neutrophil
blue
platelet
red
liver
sinusoid
healthi
left
endotoxem
right
mice
although
neutrophilplatelet
interact
detect
healthi
mice
left
notabl
differ
observ
endotoxem
mice
neutrophilplatelet
interact
common
within
liver
vasculatur
coloc
red
blue
right
scale
bar
b
schemat
show
variou
cellsurfac
molecul
platelet
neutrophil
express
platelet
shown
import
neutrophil
activ
respons
lp
jama
jamc
express
platelet
interact
neutrophil
integrin
respect
interact
platelet
also
stimul
net
releas
neutrophil
r
e
v
e
w
phagocyt
inde
platelet
bind
monocyt
neutrophil
lead
transcellular
synthesi
variou
inflammatori
molecul
even
platelet
import
immun
cell
outnumb
leukocyt
tenfold
platelet
express
mani
major
innat
immun
receptor
includ
tlr
thrombinbind
proteaseactiv
receptor
complement
receptor
numer
adhes
molecul
anim
model
indic
platelet
crucial
sepsi
acut
lung
injuri
human
thrombocytopenia
prognost
marker
poor
outcom
sepsi
major
complic
sepsi
often
occur
sickest
individu
box
although
dissemin
intravascular
coagul
bone
marrow
suppress
thought
key
reason
problem
administr
lp
caus
platelet
disappear
circul
within
hour
suggest
bone
marrow
suppress
unlik
caus
thromocytopenia
individu
platelet
sequest
organ
bind
endothelium
alreadi
adher
neutrophil
could
explain
thrombocytopenia
occur
presenc
thrombin
platelet
releas
mani
protein
circul
includ
proinflammatori
antiinflammatori
angiogen
factor
well
mediatorrich
microparticl
although
lp
also
activ
platelet
lpsinduc
platelet
respons
appear
far
subtl
induc
thrombin
fact
hallmark
featur
platelet
activ
includ
pselectin
express
platelet
aggreg
arguabl
observ
respons
lp
lp
also
induc
potent
plateletdepend
tnf
product
follow
lp
administr
mani
platelet
sequest
lung
bind
avidli
adher
neutrophil
liver
fig
plateletneutrophil
bind
shown
depend
express
platelet
suggest
anuclear
cell
activ
particip
adhes
interact
fact
activ
neutrophil
alon
injur
endothelium
bind
platelet
neutrophil
induc
endotheli
cell
death
flow
condit
platelet
shown
induc
neutrophil
releas
net
therebi
contribut
kill
bacteria
mechan
might
plateletdepend
net
mechan
requir
neutrophil
activ
lower
concentr
lp
platelet
lp
induc
nonnetrel
function
neutrophil
platelet
might
function
baromet
detect
substanti
level
bacteri
product
blood
platelet
could
bind
neutrophil
induc
net
product
last
gasp
effort
trap
destroy
bacteria
mechan
might
occur
preferenti
vast
microvasculatur
liver
lung
trap
bloodborn
bacteria
may
effici
inde
neutrophil
bind
narrow
sinusoid
liver
complet
occlud
vessel
allow
plasma
bacteria
skim
around
neutrophil
collect
releas
net
although
concentr
lp
unlik
ever
seen
infect
human
use
model
system
blood
septic
individu
equal
effect
induc
net
major
differ
lp
septic
blood
studi
account
net
format
septic
blood
suggest
addit
activ
present
septic
blood
still
mani
question
regard
role
function
neutrophil
inflamm
much
current
knowledg
base
observ
mice
translat
studi
need
evalu
clinic
import
observ
human
anoth
question
remain
address
answer
may
also
differ
mice
human
whether
differ
neutrophil
subtyp
much
like
monocyt
inde
mice
report
multipl
neutrophil
subset
uniqu
surfac
receptor
phenotyp
effector
function
experiment
endotoxemia
human
larg
mobil
bandlik
immatur
neutrophil
low
compar
high
matur
counterpart
immatur
cell
tend
less
respons
stimuli
administr
lp
show
smaller
oxid
burst
reduc
interact
bacteria
neutrophil
make
net
whether
matur
level
subtyp
unclear
possibl
popul
tissueresid
perhap
continu
recircul
pioneer
neutrophil
exist
intrigu
although
current
direct
evid
hypothesi
inde
possibl
group
neutrophil
express
high
concentr
neutrophil
chemotact
molecul
may
posit
uniqu
sentinel
popul
recruit
neutrophil
subset
continu
express
cytokin
may
also
alter
neutrophil
phenotyp
induc
express
receptor
normal
thought
recruit
monocyt
fact
neutrophil
phenotyp
may
vari
substanti
typic
septic
episod
could
last
week
understand
move
target
key
therapeut
modul
neutrophil
function
also
treatment
sepsi
conclus
theoret
intervent
point
affect
neutrophil
biolog
may
consid
treat
sepsi
includ
block
platelet
function
bind
neutrophil
net
inhibit
target
formyl
peptid
preserv
mitochondri
function
